Phase I trials usually enroll only a small number of people and test how new drugs or procedures should be administered.

Phase II trials give early information about whether or not a new drug or procedure works and also provide information about safety and benefit.

Phase III trials compare promising new drugs or procedures with the current standard treatment. Large numbers of people from across the nation usually participate in Phase III trials and receive either the new treatment or the standard treatment.